Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP344708.RAONTzX4Au3oH4ODU53Lk15VS_WN14qMCBuAjCvUPrqYE#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 17992582 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[Ultimately, molecularly based designer pharmaceuticals may emerge from this research, such as the case of trastuzumab (Herceptin) in HER-2/neu positive breast cancer, and imatinib (Gleevec) in chronic myelocytic leukemia and gastrointestinal stromal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.